Serum markers as an aid in the diagnosis of pulmonary fungal infections in AIDS patients

ABSTRACT Introduction: The etiology of pulmonary infections in HIV patients is determined by several variables including geographic region and availability of antiretroviral therapy. Materials and methods: A cross-sectional prospective study was conducted from 2012 to 2016 to evaluate the occurrence of pulmonary fungal infection in HIV-patients hospitalized due to pulmonary infections. Patients’ serums were tested for (1-3)-β-D-Glugan, galactomannan, and lactate dehydrogenase. The association among the variables was analyzed by univariate and multivariate regression analysis. Results: 60 patients were included in the study. The patients were classified in three groups: Pneumocystis jirovecii pneumonia (19 patients), community-acquired pneumonia (18 patients), and other infections (23 patients). The overall mortality was 13.3%. The time since diagnosis of HIV infection was shorter in the pneumocystosis group (4.94 years; p = 0.001) than for the other two groups of patients. The multivariate analysis showed that higher (1-3)-β-D-Glucan level (mean: 241 pg/mL) and lactate dehydrogenase (mean: 762 U/L) were associated with the diagnosis of pneumocystosis. Pneumocystosis was the aids-defining illness in 11 out of 16 newly diagnosed HIV-infected patients. Conclusion: In the era of antiretroviral therapy, PJP was still the most prevalent pulmonary infection and (1-3)-β-D-Glucan and lactate dehydrogenase may be suitable markers to help diagnosing pneumocystosis in our HIV population.

Saved in:
Bibliographic Details
Main Authors: Passos,Ana Isabela Morsch, Dertkigil,Rachel Polo, Ramos,Marcelo de Carvalho, Busso-Lopes,Ariane Fidelis, Tararan,Cibele, Ribeiro,Erivan Olinda, Schreiber,Angélica Zaninelli, Trabasso,Plinio, Resende,Mariangela Ribeiro, Moretti,Maria Luiza
Format: Digital revista
Language:English
Published: Brazilian Society of Infectious Diseases 2017
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702017000600606
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S1413-86702017000600606
record_format ojs
spelling oai:scielo:S1413-867020170006006062017-12-11Serum markers as an aid in the diagnosis of pulmonary fungal infections in AIDS patientsPassos,Ana Isabela MorschDertkigil,Rachel PoloRamos,Marcelo de CarvalhoBusso-Lopes,Ariane FidelisTararan,CibeleRibeiro,Erivan OlindaSchreiber,Angélica ZaninelliTrabasso,PlinioResende,Mariangela RibeiroMoretti,Maria Luiza Pulmonary infection HIV/AIDS (1-3)-β-D-Glugan LDH LAMP Pneumocystosis Fungal infection ABSTRACT Introduction: The etiology of pulmonary infections in HIV patients is determined by several variables including geographic region and availability of antiretroviral therapy. Materials and methods: A cross-sectional prospective study was conducted from 2012 to 2016 to evaluate the occurrence of pulmonary fungal infection in HIV-patients hospitalized due to pulmonary infections. Patients’ serums were tested for (1-3)-β-D-Glugan, galactomannan, and lactate dehydrogenase. The association among the variables was analyzed by univariate and multivariate regression analysis. Results: 60 patients were included in the study. The patients were classified in three groups: Pneumocystis jirovecii pneumonia (19 patients), community-acquired pneumonia (18 patients), and other infections (23 patients). The overall mortality was 13.3%. The time since diagnosis of HIV infection was shorter in the pneumocystosis group (4.94 years; p = 0.001) than for the other two groups of patients. The multivariate analysis showed that higher (1-3)-β-D-Glucan level (mean: 241 pg/mL) and lactate dehydrogenase (mean: 762 U/L) were associated with the diagnosis of pneumocystosis. Pneumocystosis was the aids-defining illness in 11 out of 16 newly diagnosed HIV-infected patients. Conclusion: In the era of antiretroviral therapy, PJP was still the most prevalent pulmonary infection and (1-3)-β-D-Glucan and lactate dehydrogenase may be suitable markers to help diagnosing pneumocystosis in our HIV population.info:eu-repo/semantics/openAccessBrazilian Society of Infectious DiseasesBrazilian Journal of Infectious Diseases v.21 n.6 20172017-12-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702017000600606en10.1016/j.bjid.2017.07.002
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author Passos,Ana Isabela Morsch
Dertkigil,Rachel Polo
Ramos,Marcelo de Carvalho
Busso-Lopes,Ariane Fidelis
Tararan,Cibele
Ribeiro,Erivan Olinda
Schreiber,Angélica Zaninelli
Trabasso,Plinio
Resende,Mariangela Ribeiro
Moretti,Maria Luiza
spellingShingle Passos,Ana Isabela Morsch
Dertkigil,Rachel Polo
Ramos,Marcelo de Carvalho
Busso-Lopes,Ariane Fidelis
Tararan,Cibele
Ribeiro,Erivan Olinda
Schreiber,Angélica Zaninelli
Trabasso,Plinio
Resende,Mariangela Ribeiro
Moretti,Maria Luiza
Serum markers as an aid in the diagnosis of pulmonary fungal infections in AIDS patients
author_facet Passos,Ana Isabela Morsch
Dertkigil,Rachel Polo
Ramos,Marcelo de Carvalho
Busso-Lopes,Ariane Fidelis
Tararan,Cibele
Ribeiro,Erivan Olinda
Schreiber,Angélica Zaninelli
Trabasso,Plinio
Resende,Mariangela Ribeiro
Moretti,Maria Luiza
author_sort Passos,Ana Isabela Morsch
title Serum markers as an aid in the diagnosis of pulmonary fungal infections in AIDS patients
title_short Serum markers as an aid in the diagnosis of pulmonary fungal infections in AIDS patients
title_full Serum markers as an aid in the diagnosis of pulmonary fungal infections in AIDS patients
title_fullStr Serum markers as an aid in the diagnosis of pulmonary fungal infections in AIDS patients
title_full_unstemmed Serum markers as an aid in the diagnosis of pulmonary fungal infections in AIDS patients
title_sort serum markers as an aid in the diagnosis of pulmonary fungal infections in aids patients
description ABSTRACT Introduction: The etiology of pulmonary infections in HIV patients is determined by several variables including geographic region and availability of antiretroviral therapy. Materials and methods: A cross-sectional prospective study was conducted from 2012 to 2016 to evaluate the occurrence of pulmonary fungal infection in HIV-patients hospitalized due to pulmonary infections. Patients’ serums were tested for (1-3)-β-D-Glugan, galactomannan, and lactate dehydrogenase. The association among the variables was analyzed by univariate and multivariate regression analysis. Results: 60 patients were included in the study. The patients were classified in three groups: Pneumocystis jirovecii pneumonia (19 patients), community-acquired pneumonia (18 patients), and other infections (23 patients). The overall mortality was 13.3%. The time since diagnosis of HIV infection was shorter in the pneumocystosis group (4.94 years; p = 0.001) than for the other two groups of patients. The multivariate analysis showed that higher (1-3)-β-D-Glucan level (mean: 241 pg/mL) and lactate dehydrogenase (mean: 762 U/L) were associated with the diagnosis of pneumocystosis. Pneumocystosis was the aids-defining illness in 11 out of 16 newly diagnosed HIV-infected patients. Conclusion: In the era of antiretroviral therapy, PJP was still the most prevalent pulmonary infection and (1-3)-β-D-Glucan and lactate dehydrogenase may be suitable markers to help diagnosing pneumocystosis in our HIV population.
publisher Brazilian Society of Infectious Diseases
publishDate 2017
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702017000600606
work_keys_str_mv AT passosanaisabelamorsch serummarkersasanaidinthediagnosisofpulmonaryfungalinfectionsinaidspatients
AT dertkigilrachelpolo serummarkersasanaidinthediagnosisofpulmonaryfungalinfectionsinaidspatients
AT ramosmarcelodecarvalho serummarkersasanaidinthediagnosisofpulmonaryfungalinfectionsinaidspatients
AT bussolopesarianefidelis serummarkersasanaidinthediagnosisofpulmonaryfungalinfectionsinaidspatients
AT tararancibele serummarkersasanaidinthediagnosisofpulmonaryfungalinfectionsinaidspatients
AT ribeiroerivanolinda serummarkersasanaidinthediagnosisofpulmonaryfungalinfectionsinaidspatients
AT schreiberangelicazaninelli serummarkersasanaidinthediagnosisofpulmonaryfungalinfectionsinaidspatients
AT trabassoplinio serummarkersasanaidinthediagnosisofpulmonaryfungalinfectionsinaidspatients
AT resendemariangelaribeiro serummarkersasanaidinthediagnosisofpulmonaryfungalinfectionsinaidspatients
AT morettimarialuiza serummarkersasanaidinthediagnosisofpulmonaryfungalinfectionsinaidspatients
_version_ 1756416549596430336